Mabwell (Shanghai) Bioscience Co (SHSE:688062) ROCE % : -46.26% (As of Dec. 2024)

View and export this data going back to 2022. Start your Free Trial

What is Mabwell (Shanghai) Bioscience Co ROCE %?

ROCE % measures how well a company generates profits from its capital. It is calculated as EBIT divided by Capital Employed, where Capital Employed is calculated as Total Assets minus Total Current Liabilities. Mabwell (Shanghai) Bioscience Co's annualized ROCE % for the quarter that ended in Dec. 2024 was -46.26%.

Mabwell (Shanghai) Bioscience Co ROCE % Historical Data

The historical data trend for Mabwell (Shanghai) Bioscience Co's ROCE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Mabwell (Shanghai) Bioscience Co ROCE % Chart

Mabwell (Shanghai) Bioscience Co Annual Data

Trend

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

ROCE %

Get a 7-Day Free Trial

-55.15

-52.93

-34.47

-26.67

-31.06

Mabwell (Shanghai) Bioscience Co Quarterly Data
	Dec19	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24
ROCE %	Get a 7-Day Free Trial															-39.55	-21.46	-25.78	-29.37	-46.26

Mabwell (Shanghai) Bioscience Co ROCE % Calculation

Mabwell (Shanghai) Bioscience Co's annualized ROCE % for the fiscal year that ended in Dec. 2024 is calculated as:

ROCE %	=	EBIT	/	( (Capital Employed	+	Capital Employed)	/ count )
		(A: Dec. 2024 )		(A: Dec. 2023 )		(A: Dec. 2024 )
	=	EBIT	/	( ( (Total Assets - Total Current Liabilities)	+	(Total Assets - Total Current Liabilities) )	/ count )
		(A: Dec. 2024 )		(A: Dec. 2023 )		(A: Dec. 2024 )
	=	-989.691	/	( ( (4455.048 - 816.387)	+	(4275.509 - 1541.716) )	/ 2 )
	=	-989.691	/	( (3638.661	+	2733.793)	/ 2 )
	=	-989.691	/	3186.227
	=	-31.06 %

Mabwell (Shanghai) Bioscience Co's ROCE % of for the quarter that ended in Dec. 2024 is calculated as:

ROCE %	=	EBIT ⁽¹⁾	/	( (Capital Employed	+	Capital Employed)	/ count )
		(Q: Dec. 2024 )		(Q: Sep. 2024 )		(Q: Dec. 2024 )
	=	EBIT	/	( ( (Total Assets - Total Current Liabilities)	+	(Total Assets - Total Current Liabilities) )	/ count )
		(Q: Dec. 2024 )		(Q: Sep. 2024 )		(Q: Dec. 2024 )
	=	-1338.916	/	( ( (4497.589 - 1443.086)	+	(4275.509 - 1541.716) )	/ 2 )
	=	-1338.916	/	( ( 3054.503	+	2733.793 )	/ 2 )
	=	-1338.916	/	2894.148
	=	-46.26 %

(1) Note: The EBIT data used here is four times the quarterly (Dec. 2024) EBIT data.

Mabwell (Shanghai) Bioscience Co (SHSE:688062) ROCE % Explanation

ROCE % can be especially useful when comparing the performance of capital-intensive companies. Unlike ROE %, which indicates the profitability of Shareholders Equity, ROCE % also considers long-term debt in Capital Employed. This can be helpful when analyzing companies with significant debt, as the result is neutralized by taking debt into consideration.

Generally speaking, a higher ROCE % indicates a stonger profitability for a company. Moreover, it is important to look at the ratio from a long term perspective. Investors tend to favor companies with stable and rising ROCE % trend over those with volatile ones.

Mabwell (Shanghai) Bioscience Co ROCE % Related Terms

Thank you for viewing the detailed overview of Mabwell (Shanghai) Bioscience Co's ROCE % provided by GuruFocus.com. Please click on the following links to see related term pages.

Mabwell (Shanghai) Bioscience Co Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Mabwell (Shanghai) Bioscience Co Ltd (SHSE:688062) » Definitions » ROCE %

Comparable Companies

Traded in Other Exchanges

N/A

Address

No. 230, Cailun Road, Room 105, Building 2, Pilot Free Trade Zone, Shanghai, CHN, 201210

Website

https://www.mabwell.com

Mabwell (Shanghai) Bioscience Co Ltd is engaged in the research and development, production and sales of therapeutic biological products.

Mabwell (Shanghai) Bioscience Co Headlines

No Headlines